Trials / Unknown
UnknownNCT00569101
A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 9 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this protocol is to determine whether Tacrolimus and Prednisolone are effective and safe in the treatment of the cyclophosphamide-resistant, refractory diffuse proliferative lupus nephritis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tacrolimus | during the first 2 months : tacrolimus 0.1 mg/kg + prednisolone 0.8 mg/kg p.o. ,then after : tacrolimus 0.1 mg \~0.02 mg/kg + prednisolone tapering |
Timeline
- Start date
- 2007-09-01
- Completion
- 2008-03-01
- First posted
- 2007-12-06
- Last updated
- 2007-12-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00569101. Inclusion in this directory is not an endorsement.